Copyright
©The Author(s) 2019.
World J Gastroenterol. Jul 21, 2019; 25(27): 3484-3502
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3484
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3484
Table 2 Patient and operative factors associated with cytoreductive and hyperthermic intraperitoneal chemotherapy morbidity (modified from Newton et al[70])
| Patients characteristics | Operative factors |
| Age > 60-70 yr | Pancreatic resections |
| Performance status | Bowel resection and anastomosis |
| Hypoalbuminemia | Surgeon experience |
| Peritoneal carcinomatosis index |
- Citation: Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Arjona-Sánchez Á, Rufián-Peña S, Casado-Adam Á, Cosano-Álvarez A, Briceño-Delgado J. Colorectal peritoneal metastases: Optimal management review. World J Gastroenterol 2019; 25(27): 3484-3502
- URL: https://www.wjgnet.com/1007-9327/full/v25/i27/3484.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i27.3484